The drug company Pfizer formally asked the feds Friday to approve its coronavirus vaccine for emergency use — a request that opens the door to a US release before Christmas, according to the firm.
The Manhattan-based drug company — which hinted earlier in the day they would seek approval — is now the first to seek the green light for an experimental jab from the Food and Drug Administration, which must decide whether to allow high-risk Americans to receive it by mid-December.
“It is with great pride and joy — and even a little relief — that I can say that our request for emergency use authorization for our COVID-19 vaccine is now in the FDA’s hands,” Pfizer’s chief executive, Dr. Albert Bourla, said in a video Friday. “This is a historic day.”
If the request is granted, a limited number of people — most likely first responders and health care workers — will be allowed to get the